About this trial
The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.
Eligibility criteria
Qualifiers
* Age ≥ 18 years
Fluency in French or English
Electronic consent given
Disqualifiers
Severe cognitive impairment preventing comprehension
Technical inability to access the questionnaire
Trial design
Treatments tested in this trial
- Not listed
Trial groups
11
Trial groupsSee each trial group below.